Rajasthan Cough Syrup Fails Tests, Scheme Under Scrutiny
In Rajasthan, forty samples of a government-supplied cough syrup reportedly failed quality tests, raising serious concerns about the state’s free medicine scheme. The syrup, linked to the deaths and illnesses of children in Sikar and Bharatpur, was still distributed under the scheme despite earlier bans.
Batches Banned and Inquiry Ordered
Authorities have banned 22 batches of the syrup and launched a state-level inquiry. The Rajasthan Medical Services Corporation Limited (RMSCL) has halted further procurement and is sending samples for deeper analysis.
Department’s Clarification
The state health department has stated that in the two child death cases, the syrup was given at home without doctor’s prescriptions, and that it was not dispensed through government facilities in those instances. Officials clarified that no official medical orders were issued for the drug in either case.
Systemic Issues in Oversight
Medical experts and health activists are highlighting systemic flaws: weak quality checks, procurement lapses, and regulatory gaps. They argue that allowing a previously blacklisted drug to re-enter government supply chains reflects failures in monitoring and accountability.
Renewed Debate on Cough Syrups
The controversy has also revived debate on the medical necessity of cough syrups for young children. Experts note that many such syrups, particularly those containing dextromethorphan, often offer limited benefits while posing health risks.
